Physitrack PLC has opened its electronic medical record platform to physical therapy and rehabilitation practices in every market where it operates, with the product available in English and no waitlist.
The move comes after an early access period that began on 28 September 2026 in the United States. Access was initially managed through a waitlist, but that stage has now ended.
More than 800 clinics signed up during early access, representing 5,600 end users. Physitrack said that, if all of those users convert to paid subscriptions, that would equate to €2.6m-4m in annual recurring revenue from 2027 at current pricing.
From today, any practice can register directly and start a free trial. The product remains free to use for now, with paid subscriptions scheduled to begin in January 2027.
Pricing and product plans
The EMR is sold as a standalone product, with Physitrack’s home exercise prescription platform available as an optional add-on. Practices signing up before 1 January 2027 will keep a founder rate of $39.99 per user per month for 12 months from the date charging begins. For sign-ups from 1 January 2027, the EMR will cost $59.99 per user per month.
Users can also add Physitrack’s Home Exercise Prescription platform for $23.99 per user per month and an AI scribe for $19 per user per month. Additional charges will apply for Remote Therapeutic Monitoring in the United States, as well as telehealth and billing.
The EMR already supports patient self-pay billing. Revenue cycle management and insurance claims workflows, including the previously announced Claim.MD integration, are planned from January 2027 for the United States, Australia, the United Kingdom and Canada.
Global demand and early ranking
Demand extended well beyond the market the early access period was designed for. Physitrack said the waitlist drew more than 800 clinic registrations from 60 countries, without paid promotion.
The company also said the global physical therapy EMR total addressable market is around $1.43 billion to $1.60 billion today, and projected to grow to $2.5 billion to $3.4 billion by 2030 to 2035. English-speaking markets account for around two thirds of that total, or about $0.95 billion to $1.10 billion today.
Five weeks after launch, Physitrack EMR is ranked third among EMR software for physical therapy on G2, the independent review platform. G2 rankings are based on verified user reviews and the platform does not accept paid placements.
Management view
Chief executive and founder Henrik Molin said: “We said in September that we would launch properly, listen to the practices using it and then scale,” said Henrik Molin, CEO and Founder of Physitrack PLC.
He added: “The product has been in the hands of clinicians for five weeks, activation and usage has exceeded 70% of early access users, we have learned a great deal from them, and we are now confident enough to open it to everyone.”
Molin also said: “We are pleased to see significant interest from across the globe and I can confirm the EMR will be available for English language users wherever they are based.”
He said the company’s commercial discipline had not changed and that charging would begin in the new year. He added that the size of the opportunity had “multiplied” since the product first launched for US users only.
Physitrack is also exploring whether to adapt the EMR for additional manual care specialists, including chiropractors and osteopaths. The company said it is also open to launching access for mental health and general healthcare segments in future.
